What does PHARMACIE DU MIDI do?

PHARMACIE DU MIDI is a pharmacy in Sint-Gillis (bij-Brussel). Private Limited, started on 20 June 2017, 1 establishment.

What is the address of PHARMACIE DU MIDI?

The registered office of PHARMACIE DU MIDI is located at Fonsnylaan 29, 1060 Sint-Gillis (bij-Brussel).

Is PHARMACIE DU MIDI still active?

Yes. According to the CBE (2 November 2026) PHARMACIE DU MIDI is active, legal situation “Normale toestand”, started on 20 June 2017.

Is PHARMACIE DU MIDI registered on Peppol?

Yes, PHARMACIE DU MIDI is registered on the Peppol network with ID 0208:0676991407.

What is the enterprise number of PHARMACIE DU MIDI?

The enterprise number of PHARMACIE DU MIDI is BE0676991407.

When was PHARMACIE DU MIDI founded?

PHARMACIE DU MIDI was founded on 20 June 2017.

Who are the directors of PHARMACIE DU MIDI?

According to the 2025 annual accounts, the directors of PHARMACIE DU MIDI are: FRANCOISE HANCISSE, THIERRY VAN DURME.

Is PHARMACIE DU MIDI a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 June 2017; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did PHARMACIE DU MIDI make in 2025?

PHARMACIE DU MIDI posted a profit after taxes of € 25,617 in financial year 2025.

What is the revenue of PHARMACIE DU MIDI?

As a small company, PHARMACIE DU MIDI is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 124,746.

How much does an employee at PHARMACIE DU MIDI earn?

The average wage cost per full-time employee at PHARMACIE DU MIDI was € 61,900 in 2025: staff costs of € 86,700 for 1.4 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE DU MIDI have?

According to the 2025 annual accounts, PHARMACIE DU MIDI has 1.4 full-time equivalents (FTE).

PHARMACIE DU MIDI (Private Limited) - Sint-Gillis (bij-Brussel)

Dossier PHARMACIE DU MIDI, printed on 2 November 2026 from databakkes.be/en/0676991407/pharmacie-du-midi. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE DU MIDI from Sint-Gillis (bij-Brussel), company number BE0676991407, closed financial year 2025 with a result of € 25,617 after tax. For that financial year PHARMACIE DU MIDI recorded a gross margin of € 124,746 and equity of € 213,737. Compared with financial year 2024, the result moved from € 51,889 to € 25,617. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 8, 2026.

What it is worth Growing

€ 213,737

▲ 14% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 25,617

▼ 51% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 113,911

▼ 1% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 195,137.

People and assets in 2025

Full-time equivalents

1.4

▼ 0.4 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 86,700

▼ 8% vs 2024

€ 61,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 26,236

▼ 38% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 21,842

▼ 7% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 165,347 Gross margin 2022: € 165,347 First fiscal year in the series	€ 176,140 Gross margin 2023: € 176,140 ▲ 7% vs 2022 (€ 165,347) Favourable step	€ 168,138 Gross margin 2024: € 168,138 ▼ 5% vs 2023 (€ 176,140) Unfavourable step	€ 124,746 Gross margin 2025: € 124,746 ▼ 26% vs 2024 (€ 168,138) Unfavourable step	▼ 26%
Profit after taxes	€ 52,089 Profit after taxes 2022: € 52,089 First fiscal year in the series	€ 54,319 Profit after taxes 2023: € 54,319 ▲ 4% vs 2022 (€ 52,089) Favourable step	€ 51,889 Profit after taxes 2024: € 51,889 ▼ 4% vs 2023 (€ 54,319) Unfavourable step	€ 25,617 Profit after taxes 2025: € 25,617 ▼ 51% vs 2024 (€ 51,889) Unfavourable step	▼ 51%
Equity	€ 101,911 Equity 2022: € 101,911 First fiscal year in the series	€ 156,230 Equity 2023: € 156,230 ▲ 53% vs 2022 (€ 101,911) Favourable step	€ 188,120 Equity 2024: € 188,120 ▲ 20% vs 2023 (€ 156,230) Favourable step	€ 213,737 Equity 2025: € 213,737 ▲ 14% vs 2024 (€ 188,120) Favourable step	▲ 14%
Total debts	€ 283,028 Total debts 2022: € 283,028 First fiscal year in the series	€ 71,304 Total debts 2023: € 71,304 ▼ 75% vs 2022 (€ 283,028) Favourable step	€ 85,997 Total debts 2024: € 85,997 ▲ 21% vs 2023 (€ 71,304) Unfavourable step	€ 68,295 Total debts 2025: € 68,295 ▼ 21% vs 2024 (€ 85,997) Favourable step	▼ 21%
Cash	€ 225,423 Cash 2022: € 225,423 First fiscal year in the series	€ 86,378 Cash 2023: € 86,378 ▼ 62% vs 2022 (€ 225,423) Unfavourable step	€ 114,504 Cash 2024: € 114,504 ▲ 33% vs 2023 (€ 86,378) Favourable step	€ 113,911 Cash 2025: € 113,911 ▼ 1% vs 2024 (€ 114,504) Unfavourable step	▼ 1%
Retained profit	€ 83,311 Retained profit 2022: € 83,311 First fiscal year in the series	€ 137,630 Retained profit 2023: € 137,630 ▲ 65% vs 2022 (€ 83,311) Favourable step	€ 169,520 Retained profit 2024: € 169,520 ▲ 23% vs 2023 (€ 137,630) Favourable step	€ 195,137 Retained profit 2025: € 195,137 ▲ 15% vs 2024 (€ 169,520) Favourable step	▲ 15%
Dividend	€ 17,500 Dividend 2022: € 17,500 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 17,500) Unchanged	€ 20,000 Dividend 2024: € 20,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 20,000) Unchanged	▼ 100%
Balance sheet total	€ 384,939 Balance sheet total 2022: € 384,939 First fiscal year in the series	€ 227,534 Balance sheet total 2023: € 227,534 ▼ 41% vs 2022 (€ 384,939) Unchanged	€ 274,117 Balance sheet total 2024: € 274,117 ▲ 20% vs 2023 (€ 227,534) Unchanged	€ 282,032 Balance sheet total 2025: € 282,032 ▲ 3% vs 2024 (€ 274,117) Unchanged	▲ 3%
Employees (FTE)	2.3 Employees (FTE) 2022: 2.3 First fiscal year in the series	1.8 Employees (FTE) 2023: 1.8 ▼ 0.5 vs 2022 (2.3) Unchanged	1.8 Employees (FTE) 2024: 1.8 Unchanged (1.8) Unchanged	1.4 Employees (FTE) 2025: 1.4 ▼ 0.4 vs 2024 (1.8) Unchanged	▼ 0.4

Key figures of PHARMACIE DU MIDI, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE DU MIDI?

What happened at PHARMACIE DU MIDI in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 8, 2026 New annual accounts for financial year 2025: profit of € 25,617 (▼ 51% vs 2024). Source: NBB ↗
Jun 20, 2017 New establishment in Sint-Gillis (bij-Brussel). KBO
2017 FRANCOISE HANCISSE became a director. NBB
2017 THIERRY VAN DURME became a director. NBB
Jun 20, 2017 Start of the company according to the CBE. KBO

In short

From € 52,089 profit in 2022 to € 25,617 profit in 2025.

Paid € 56,926 in corporate taxes since 2022.

Best year ever: 2023, with € 54,319 profit.

On average € 89,100 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

FRANCOISE HANCISSE THIERRY VAN DURME

PHARMACIE DU QUARTIER LEOPOLD - EUROPE

IMMO VAN DURME HANCISSE

PHARMACIE DU QUARTIER BREUGHEL

PHARMACIE DU MIDI

Behind PHARMACIE DU MIDI are FRANCOISE HANCISSE and THIERRY VAN DURME. The same people are also behind IMMO VAN DURME HANCISSE, PHARMACIE DU QUARTIER BREUGHEL, PHARMACIE DU LUXEMBOURG and PHARMACIE DE FOREST. FRANCOISE HANCISSE is also behind PHARMACIE DU QUARTIER LEOPOLD - EUROPE.

Directors

According to the 2025 annual accounts

FRANCOISE HANCISSE

Manager

Also active at: PHARMACIE DU QUARTIER LEOPOLD - EUROPE, IMMO VAN DURME HANCISSE, PHARMACIE DU QUARTIER BREUGHEL, PHARMACIE DU LUXEMBOURG, PHARMACIE DE FOREST

since 2017

THIERRY VAN DURME

Manager

Also active at: IMMO VAN DURME HANCISSE, PHARMACIE DU QUARTIER BREUGHEL, PHARMACIE DU LUXEMBOURG, PHARMACIE DE FOREST

since 2017

Establishments

Establishment units

Physical locations of this company

Registered office

Fonsnylaan 29

1060 Sint-Gillis (bij-Brussel)

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0676.991.407
VAT number: BE 0676.991.407
Registered office: Fonsnylaan 29, 1060 Sint-Gillis (bij-Brussel)
Names & denominations: PHARMACIE DU MIDI
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 20 June 2017
Peppol: Active · Active since 30 Nov 2025
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗